Related Experiment Videos
MK-801 prevents microglial reaction in rat hippocampus after forebrain ischemia
W J Streit1, T Morioka, A N Kalehua
1Department of Neuroscience, University of Florida, Gainesville 32610.
Abstract:
Delayed neuronal death induced by transient forebrain ischemia in the rat hippocampus is preceded by a prominent microglial reaction which begins within minutes after the ischemic injury. In the present study we have examined the effect of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 on microglial activation and neuronal survival. Using lectin histochemistry to detect microglia, we show that the systemic administration of MK-801 prior to ischemia prevents microglial activation, as well as delayed death of CA1 pyramidal neurons. The results demonstrate that early blockage of the glutamate cascade prevents microglial activation, and could suggest a role for microglia in mediating ischemic injury.
Insights
Early administration of MK-801, an N-methyl-D-aspartate (NMDA) receptor antagonist, prevents microglial activation and neuronal death following ischemic injury in rats. This suggests that blocking the glutamate cascade may protect against brain damage by inhibiting microglial responses.
Area of Science:
- Neuroscience
- Ischemic injury research
- Neuroinflammation
Background:
- Transient forebrain ischemia in rats leads to delayed neuronal death in the hippocampus.
- This neuronal death is preceded by rapid microglial activation, starting within minutes of the ischemic event.
Purpose of the Study:
- To investigate the impact of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 on microglial activation and neuronal survival after ischemic injury.
- To determine if early blockade of the glutamate cascade influences the inflammatory response and subsequent neuronal damage.
Main Methods:
- Systemic administration of MK-801 before inducing transient forebrain ischemia in rats.
- Lectin histochemistry was used to detect and quantify microglial activation.
- Assessment of delayed death in CA1 pyramidal neurons in the hippocampus.
Main Results:
- Pre-ischemic administration of MK-801 effectively prevented microglial activation.
- MK-801 treatment also inhibited the delayed death of CA1 pyramidal neurons.
- Early blockage of the glutamate cascade via NMDA receptor antagonism suppressed microglial responses.
Conclusions:
- Early blockade of the glutamate cascade, specifically through NMDA receptor antagonism, is effective in preventing microglial activation post-ischemia.
- The findings suggest a potential role for microglia in mediating ischemic neuronal injury.
- Targeting NMDA receptors early may offer a neuroprotective strategy against ischemic brain damage.